Zafgen to Present at the Wedbush PacGrow Healthcare Conference
06 Agosto 2019 - 5:15PM
Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical
company leveraging its proprietary knowledge of MetAP2 systems
biology to develop novel therapies for patients affected by a range
of metabolic diseases, announced today that Jeffrey Hatfield, Chief
Executive Officer of Zafgen, Inc. is scheduled to present at the
Wedbush PacGrow Healthcare Conference on Tuesday, August 13, 2019,
at 8:00 a.m. ET.
A live audio webcast and replay of the presentation will be
available through the Events and Presentations page of the
Investors section of the Company's website (www.zafgen.com) for 90
days following the conclusion of the live event.
About ZafgenZafgen (Nasdaq:ZFGN) is a
clinical-stage biopharmaceutical company leveraging its proprietary
MetAP2 biology platform to develop novel therapies for patients
affected by complex metabolic diseases. Zafgen has pioneered the
study of MetAP2 inhibitors in both common and rare metabolic
disorders. Learn more at www.zafgen.com.
Media/Investor Relations Contacts:Zafgen, Inc.
Patricia Allen Chief Financial Officer 617-648-9792
MediaKrystle GibbsTen Bridge Communications
krystle@tenbridgecommunications.com508-479-6358
InvestorsJohn
WoolfordWestwickejohn.woolford@westwicke.com443-213-0506
Zafgen (NASDAQ:ZFGN)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Zafgen (NASDAQ:ZFGN)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Zafgen Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de